| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 06/17/2004 | US20040115201 treatment of an apoptosis-related disease by administering an inhibitor of the MKLP1 polypeptide; diagnostic and prognostic processes in connection with apoptosis relates diseases, and screening processes aimed at obtaining MKLP1 modulators. |
| 06/17/2004 | US20040115189 especially injectable and spray pharmaceutical formulations. |
| 06/17/2004 | US20040115188 Enzyme with proteolytic activity |
| 06/17/2004 | US20040115185 Placental alkaline phosphatase to control diabetes |
| 06/17/2004 | US20040115184 Methods and compositions for modifying apolipoprotein b mrna editing |
| 06/17/2004 | US20040115183 Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-senstive diseases |
| 06/17/2004 | US20040115128 Targeting endothelium for tissue-specific delivery of agents |
| 06/17/2004 | DE10330686A1 Neue Neomycin-Phosphotransferase-Gene und Verfahren zur Selektion von Hochproduzierenden rekombinanten Zellen New neomycin phosphotransferase genes and methods for the selection of high-producing recombinant cells |
| 06/17/2004 | DE10255597A1 New polynucleotide encoding (S)-hydroxynitrilase, useful for preparation of cyanohydrins, used as intermediates for e.g. pyrethroids, is a mutated form of the manioc gene |
| 06/17/2004 | DE10254074A1 Verfahren zur mikrobiellen Herstellung von Stoffwechselprodukten A process for the microbial production of metabolic products |
| 06/17/2004 | DE10248166A1 Anti-Kazlauskas-Lipasen Anti-Kazlauskas lipases |
| 06/17/2004 | CA2706873A1 Modified neomycin-phosphotransferase gene that increases expression rates of co-integrated gene and uses thereof |
| 06/17/2004 | CA2507626A1 Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents |
| 06/17/2004 | CA2507007A1 Bioremediation with transgenic plants |
| 06/17/2004 | CA2506748A1 Method for in vitro selection of 2'-substituted nucleic acids |
| 06/17/2004 | CA2485957A1 Protease inhibitor |
| 06/16/2004 | EP1428891A1 Novel gene nedl-1 |
| 06/16/2004 | EP1428884A1 Sulfohydrolase I from Chondrus crispus seaweed, and uses thereof |
| 06/16/2004 | EP1428876A1 Novel amide hydrolase gene |
| 06/16/2004 | EP1428875A1 Method of diagnosis of obesity |
| 06/16/2004 | EP1428874A2 Lipase variant |
| 06/16/2004 | EP1428873A2 Method for producing y-glutamylcysteine |
| 06/16/2004 | EP1427857A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 06/16/2004 | EP1427846A2 Method of identifying glycosyl transferase binding compounds |
| 06/16/2004 | EP1427842A2 Mid 9002, a human sulfatase family member and uses therefor |
| 06/16/2004 | EP1427838A1 Plant enzymes for bioconversion |
| 06/16/2004 | EP1427836A2 Pseudotyped retroviral vector system |
| 06/16/2004 | EP1427832A2 Methyltransferase genes and uses thereof |
| 06/16/2004 | EP1427820A2 Modified factor ix |
| 06/16/2004 | EP1427819A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
| 06/16/2004 | EP1427818A2 Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2-osidic sidechains |
| 06/16/2004 | EP1427749A2 Novel proteins and nucleic acids encoding same |
| 06/16/2004 | EP1427439A1 Gamma three protease |
| 06/16/2004 | EP1427379A2 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 06/16/2004 | EP1427293A1 Glutaminase |
| 06/16/2004 | EP1221830A4 Expression of phytase in plants as a method of modifying plant productivity |
| 06/16/2004 | EP1127105A4 Plants having enhanced gall resistance and methods and compositions for producing same |
| 06/16/2004 | EP1108010A4 Salt-tolerant transgenic turfgrass |
| 06/16/2004 | EP1009810B1 Mutant thermomonospora spp. cellulase |
| 06/16/2004 | EP1005540B1 Ikk-beta proteins, nucleic acids and methods |
| 06/16/2004 | EP0865499A4 Production of lysosomal enzymes in plant-based expression systems |
| 06/16/2004 | EP0791078B1 Methods for drug screening |
| 06/16/2004 | EP0753058B1 High-alkaline protease and its use |
| 06/16/2004 | EP0672133B1 TNF-alpha RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-alpha RIBOZYMES |
| 06/16/2004 | CN1505682A Methods and compositions for simultaneous saccharification and fermentation |
| 06/16/2004 | CN1505679A Alkaline protease variants, and detergents and cleaning agents containing the same |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1504753A Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same |
| 06/16/2004 | CN1504577A Process for producing L-methionine, aminoacylase strain and aminoacylase |
| 06/16/2004 | CN1504569A Chromatography purification process of viper venom blood clotting enzyme |
| 06/16/2004 | CN1504568A Earthworm plasmin multi-component and the separating, purifying and preparing technology thereof |
| 06/16/2004 | CN1504567A Non-reducing saccharide-forming enzyme, trehalose-releasing enzyme, and process for producing saccharides using the same enzymes |
| 06/16/2004 | CN1153832C Thermophilic alkaline phosphoesterase and its expression |
| 06/16/2004 | CN1153830C Modulators of anchoring protein function |
| 06/15/2004 | US6750229 Administering to a mammal a pigmentation-changing effective amount of a bowman-birk inhibitor or of natural extract containing a bowman-birk inhibitor |
| 06/15/2004 | US6750201 Peptide which promotes binding of scupa to lm-tk- cells and thereby promotes internalization and degradation of scupa by those cells |
| 06/15/2004 | US6750197 Activators of endothelial nitric oxide synthase |
| 06/15/2004 | US6750057 Ubiquitin ligase |
| 06/15/2004 | US6750046 Preparation of thioredoxin and thioredoxin reductase proteins on oil bodies |
| 06/15/2004 | US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans |
| 06/15/2004 | US6750027 Enzymatic polypeptide for use in the treatment, diagnosis and prevention of cancer, autoimmune and nervous system disorders |
| 06/15/2004 | US6750020 Method for alteration detection |
| 06/15/2004 | CA2285921C Composition and method for treatment of cmv infections |
| 06/10/2004 | WO2004048595A2 Vascular-preferred promoters |
| 06/10/2004 | WO2004048592A2 Bgl7 beta-glucosidase and nucleic acids encoding the same |
| 06/10/2004 | WO2004048576A1 Phosphorylated ndr kinase |
| 06/10/2004 | WO2004048563A1 Dna polymerase isolated from aeropyrum pernix and its preparation method |
| 06/10/2004 | WO2004048562A1 PROCESSES FOR PRODUCING HUMAN-ORIGIN β1,3-N-ACETYLGLUCOSAMINYL TRANSFERASE 2 |
| 06/10/2004 | WO2004048561A1 Enzymatic reaction system comprising a pqq-dependent alcohol dehydrogenase and a quinoid redox cofactor compound |
| 06/10/2004 | WO2004048560A1 Method for mass-producing of a recombinant human tyrosinase in e. coli |
| 06/10/2004 | WO2004048559A1 Metabolically engineered micro-organisms having reduced production of undesired metabolic products |
| 06/10/2004 | WO2004048558A2 Heparanase mediated cell adhesion and uses thereof |
| 06/10/2004 | WO2004048549A2 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 06/10/2004 | WO2004048544A2 Ca ix-specific inhibitors |
| 06/10/2004 | WO2004048540A2 Mracs as modifiers of the rac pathway and methods of use |
| 06/10/2004 | WO2004048538A2 Csnks as modifiers of the rac pathway and methods of use |
| 06/10/2004 | WO2004048531A2 Modulation of death-associated protein kinase 1 expression |
| 06/10/2004 | WO2004048517A2 Method for reducing or preventing modification of a polypeptide in solution |
| 06/10/2004 | WO2004048512A2 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | WO2004048498A1 Antioxidant, skin preparation for external use, cosmetic and food |
| 06/10/2004 | WO2004047856A1 Cancer metastasis inhibitor |
| 06/10/2004 | WO2004047746A2 Regulation of stearoyl-coa desaturase to treat obesity |
| 06/10/2004 | WO2004047720A2 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 06/10/2004 | WO2004035010A8 Methods and organisms for production of b6 vitamers |
| 06/10/2004 | WO2004013343A3 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004004698A3 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/10/2004 | WO2004003189A3 Regulation of human phospholipase c-like protein |
| 06/10/2004 | WO2004001008A3 Kinases and phosphatases |
| 06/10/2004 | WO2004000994A3 Novel acetylcholinesterase gene responsible for insecticide resistance and applications thereof |
| 06/10/2004 | WO2003106632A3 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 06/10/2004 | WO2003106476A8 Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity |
| 06/10/2004 | WO2003104470A3 Retrons for gene targeting |
| 06/10/2004 | WO2003104390A3 Adamts nucleic acids and proteins |
| 06/10/2004 | WO2003099224A3 Antisense moodulation of kinesin-like 1 expression |
| 06/10/2004 | WO2003089641A3 Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems |
| 06/10/2004 | WO2003089636A9 FUSION PROTEIN CONTAINING THE ACTIVITY OF β1, 4-N-ACETYLGALACTOSAMINYLTRANSFERASE, GENE ENCODING THE FUSION PROTEIN AND THE TRANSFORMED CELLS TRANSFECTED BY THE GENE |
| 06/10/2004 | WO2003089571A3 Ehrlichia canis genes and vaccines |
| 06/10/2004 | WO2003080855A3 Deracemisation of amines |
| 06/10/2004 | WO2003074666A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |